Lutetium-177Lu chloride Billev
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lutetium-177Lu chloride Billev, covering 2024-11-29 to 2024-11-29. Get the full timeline:
Most recent: EMA Authorised: Lutetium (177Lu) chloride Billev (previously Illuzyce) (lutetium (177Lu) chloride) — Billev Pharma Aps